Mary E Klotman, MD

Professor of Medicine
R.J. Reynolds Professor of Medicine
Dean, School of Medicine
Professor in Molecular Genetics and Microbiology
Professor of Pathology
Member of the Duke Human Vaccine Institute
Campus mail DUMC 2927, Davison Building Room 125, Durham, NC 27710
Phone (919) 684-2455
Email address mary.klotman@duke.edu

Dr. Klotman became dean of the Duke School of Medicine in June 2017.

An accomplished clinician and scientist, Klotman’s research interests are focused on the molecular pathogenesis of Human Immunodeficiency Virus 1 (HIV-1) infection.

Among many important contributions to this field, Klotman and her team demonstrated that HIV resides in and evolves separately in kidney cells, a critical step in HIV-associated kidney disease. Her research group also has determined the role of soluble host factors involved in an innate immune response to HIV in an effort to improve prevention strategies, topical microbicides that could be used to block sexual transmission of HIV.

Most recently, her group has been defining the role of integrase-defective lentiviral vectors for the delivery of an HIV vaccine. (Read the announcement.)

In Their Words

Education and Training

  • Fellow in Infectious Diseases, Medicine, Duke University, 1983 - 1985
  • Resident, Medicine, Duke University, 1980 - 1983
  • M.D., Duke University, 1980

Publications

Fierer, DS, and Klotman, ME. "Kidney and central nervous system as reservoirs of HIV infection." Curr Opin HIV AIDS 1, no. 2 (March 2006): 115-120.

PMID
19372794
Full Text

Zerhouni-Layachi, B, Husain, M, Ross, MJ, Marras, D, Sunamoto, M, Liu, X, Klotman, PE, and Klotman, ME. "Dual tropism of HIV-1 envelopes derived from renal tubular epithelial cells of patients with HIV-associated nephropathy." AIDS 20, no. 4 (February 28, 2006): 621-624.

PMID
16470129
Full Text

Wyatt, CM, Arons, RR, Klotman, PE, and Klotman, ME. "Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality." AIDS 20, no. 4 (February 28, 2006): 561-565.

PMID
16470120
Full Text

Keller, MJ, Zerhouni-Layachi, B, Cheshenko, N, John, M, Hogarty, K, Kasowitz, A, Goldberg, CL, Wallenstein, S, Profy, AT, Klotman, ME, and Herold, BC. "PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial." J Infect Dis 193, no. 1 (January 1, 2006): 27-35.

PMID
16323128
Full Text

Mosoian, A, Teixeira, A, High, AA, Christian, RE, Hunt, DF, Shabanowitz, J, Liu, X, and Klotman, M. "Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages." Journal of Virology 80, no. 18 (2006): 9200-9206.

PMID
16940531
Full Text

Husain, M, D'Agati, VD, He, JC, Klotman, ME, and Klotman, PE. "HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN." AIDS 19, no. 17 (November 18, 2005): 1975-1980.

PMID
16260903
Scholars@Duke

John, M, Keller, MJ, Fam, EH, Cheshenko, N, Hogarty, K, Kasowitz, A, Wallenstein, S, Carlucci, MJ, Tuyama, AC, Lu, W, Klotman, ME, Lehrer, RI, and Herold, BC. "Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection." J Infect Dis 192, no. 10 (November 15, 2005): 1731-1740.

PMID
16235171
Full Text

Scordi-Bello, IA, Mosoian, A, He, C, Chen, Y, Cheng, Y, Jarvis, GA, Keller, MJ, Hogarty, K, Waller, DP, Profy, AT, Herold, BC, and Klotman, ME. "Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action." Antimicrob Agents Chemother 49, no. 9 (September 2005): 3607-3615.

PMID
16127029
Full Text

Schwartz, EJ, Szczech, LA, Ross, MJ, Klotman, ME, Winston, JA, and Klotman, PE. "Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease." J Am Soc Nephrol 16, no. 8 (August 2005): 2412-2420.

PMID
15987747
Full Text

Gillim-Ross, L, Cara, A, and Klotman, ME. "Nef expressed from human immunodeficiency virus type 1 extrachromosomal DNA downregulates CD4 on primary CD4+ T lymphocytes: implications for integrase inhibitors." J Gen Virol 86, no. Pt 3 (March 2005): 765-771.

PMID
15722538
Full Text

Pages